Your Health, We Care
Ceritinib is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.
from FDA，2021.10
Suitable for treating adult patients with metastatic non-small cell lung cancer ···【more】
Release date：2026-01-05Recommended：6
LuciusVersionofCeritinib:DosageandAdministration,Indications,PrecautionsIndicati···【more】
Release date：2025-12-12Recommended：59
